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Abstract - In 2002 physician-assisted dying was legally regulated in the Netherlands and Belgium. Besides fundamental and 
ethical objections to physician-assisted dying, one of the frequently expressed pragmatic concerns is that legal regulation of 
physician-assisted dying, as implemented in the Netherlands and Belgium, could stunt the development of palliative care and 
erode its culture of competent and compassionate care. We here review these controversies and test the hypothesis that legal 
physician-assisted dying impeded the development of palliative care in the Netherlands and Belgium. 
We collected the data over time on the funding of palliative care in Belgium. Next, using the data of the European Association 
for Palliative Care‟s 2007 Atlas of Palliative Care, we compared the state of development of palliative care in Western-European 
countries with and without legally regulated physician-assisted dying. 
In Belgium, government expenditure for palliative care grew consistently by a yearly average of 10% over the 5 years fol-
lowing legal regulation of physician-assisted dying. As assessed in 2005, palliative care development in the Netherlands and 
Belgium did not lag behind Western-European countries without legally regulated physician-assisted dying, and was close to on 
a par with the UK, the benchmark country. 
In conclusion, the hypothesis that legal regulation of physician-assisted dying stunts the development of palliative care is not 
supported by the Belgian and Dutch experience of the first several years. Continued monitoring of both permissive and 
non-permissive countries is needed to assess possible longer-term effects. 
Keywords - Development of palliative care, jurisdictions with and without legal physician-assisted dying, the Netherlands, 
Belgium, European countries. 
 
 
1. Introduction 
Short review of the controversies raised by the Benelux 
countries’ end-of-life legislations 
Physician-assisted dying, i.e. physician-assisted suicide and 
euthanasia, the latter defined as ending a person‟s life at their 
explicit request, is in Europe legally regulated only in Bel-
gium and the Netherlands since 2002 and Luxembourg since 
2009.The legal conditions of prudence include an explicit and 
repeated request by a competent adult patient whose physical 
or mental suffering by an irreversible medical condition is 
“unbearable” and without any perspective of improvement. 
Also procedural precautions, including independent peer 
consultation, must be observed and cases must be reported to 
a review commission (Deliens & van der Wal, 2003). The 
experience of the Benelux countries is under intense scrutiny, 
all the more because legally regulating physician-assisted 
dying is being debated in several other countries. 
Can palliative care and physician-assisted dying be com-
plementary, as posited for the Belgian model of end-of-life 
care(Bernheim, Deschepper, Distelmans, Mullie, Bilsen, & 
Deliens, 2008), or are they incompatible? Several recent 
publications take the latter position, specifically challenging 
the Belgian construct of „integral palliative care‟ and arguing 
that physician-assisted dying and palliative care are funda-
mentally antagonistic causes (Jaspers, Müller-Busch & Nauck, 
2009; Kettler & Nauck, 2010; Johnstone, 2012; Materstvedt, 
2012). The principled rejection of „integral palliative care‟ is 
in line with traditional views in mainstream palliative care 
(Roy &Rapin, 1994; Hamel, 1998; Mast, Salama, Silverman, 
& Arnold, 2004; Meisel, 2005; Stephenson, 2006; Bosshard, 
Broeckaert,Clark, Materstvedt, Gordijn& Müller-Busch, 
2008). Indeed, the prevention of physician-assisted dying was 
one of the prime motivations of the founders of the palliative 
care movement (Saunders, 1976) and this tenet has remained 
widely endorsed ever since (Gordijn& Janssens, 2000; 
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Müller-Busch, Oduncu, Woskanjan, & Klaschik, 2004).  
Over and beyond such fundamental ethical stances, also 
pragmatic objections to legally regulated physician-assisted 
dying are frequently expressed, including the risks of slip-
pery-slope effects and of erosion of public confidence in the 
healthcare services(Materstvedt et al., 2003; Finlay, 
Wheatley& Izdebski, 2005; Gamester & Van den Eynden, 
2009; Pereira, 2011). The debate on these practical issues is 
ongoing. Epidemiological data from Oregon, the Netherlands 
and Belgium tend to allay these fears (Quill, 2007; Battin, van 
der Heide, Ganzini, van der Wal, & Onwuteaka-Philipsen, 
2007; Bernheim & Mullie, 2010; Chambaere, Bilsen, Cohen, 
Onwuteaka-Philipsen, Mortier, & Deliens, 2010, 2011; 
Downie, Chambaere & Bernheim, 2012; Rietjens, 
Deschepper, Pasman, & Deliens, 2012). While the epidemi-
ological study results are hardly disputed, there are expres-
sions of scepticism as to the validity of conclusions (Ma-
terstvedt, 2009) and criticisms of the imperfections in the 
enforcement of the Belgian law‟s prescriptions of prudence 
(Cohen-Almagor, 2013). 
We here focus on a related, intellectually legitimate, 
pragmatic concern: the oft-invoked fear that legally regulated 
physician-assisted dying would impede the development of 
palliative care. This could happen if legally regulating physi-
cian-assisted dying would erode the competent and compas-
sionate care culture of palliative care, reduce demand for 
palliative care, draw attention and efforts away from palliative 
care and if governments would be tempted to save on scarce 
health-care resources by neglecting palliative care, thus 
nudging citizens and physicians towards the quick fix of 
physician-assisted dying (Saunders, 1976; Gordijn& Janssens, 
2000; Materstvedt et al., 2003; Finlay, Wheatley & Izdebski, 
2005; Gamester & Van den Eynden, 2009; Pereira, 2011; 
Johnstone, 2012).  
2. Methods 
The hypothesis that legal regulation of physician-assisted 
dying could stunt the financial support of palliative care was 
investigated by seeking the governmental data on the funding 
of palliative care. These were found available only for Bel-
gium (source details in the legend of Figure 1). Next, we 
compared the state of development of palliative care in Eu-
ropean countries with and without legally regulated physi-
cian-assisted dying according to the indicators provided by 
the European Association for Palliative Care‟s Atlas of Pal-
liative Care.  
 
Figure 1. Total national expenditure on palliative care 1998-2007 (in million €) 
Source data 1999/2001: press communication by the Federal Secretary for Health in 2001: http://oud.frankvandenbroucke.be/html/soc/P-011029.htm (last 
accessed 13 June 2013), and converted from Belgian francs to Euros with the exchange rate of the introduction of the Euro in Belgium (1 EUR = 40.3399 Belgian 
francs).  
Source data for federal expenditure for palliative care 2002-2007: Federal Evaluation Cell on Palliative Care. [Evaluation Report Palliative Care 2008] (in Dutch). 
Brussels: Federal Government Department Public Health, Food Safety and Environment, DG Organisation Health Care Services, Cell Chronic, Elderly and 
Palliative Care, 2008. Available at: http://www.health.belgium.be/internet2Prd/groups/public/@public/@dg1/@acutecare/documents/ie2divers/15720532.pdf 
(last accessed 13 June 2013). 
Government expenditure is made up of funding of PC partnerships (federations and networks), PC at home (multidisciplinary support teams, reimbursement for 
palliative nursing, GP visits and physical therapy at home) and PC in hospitals (PCUs and PSTs) These figures exclude expenses for PC in day care centres and 
care homes, which are not available. 
Data are inflation adjusted, using the World Economic Outlook (WEO) EconStats data, IMF: http://www.econstats.com/weo/V016.htm. (last accessed 13 June 
2013). 
Data for government expenditure in 2000 are lacking. In 1998 there was no government funding for PC, nor a reimbursement system for health care costs 
pertaining to PC. 
The atlas is based on a survey of national experts and 
palliative care organisations carried out in 2005 by the EAPC 
Task Force on Palliative Care Development (Centeno et al., 
2007a & b).As in the 2011 EAPC report to the UK Commis-
sion on Assisted Dying (Chambaere et al., 2011), we com-
pared the available indicators of the state of development of 
palliative care in four large Western European countries 
where physician-assisted dying is illegal (UK, France, Ger-
many and Spain) with the Netherlands and Belgium. The five 
available structural indicators, which reflect the supply of 
services offered by professional palliative care to the public, 
are the per capita numbers of inpatient palliative care units 
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and hospices, palliative care beds, support teams in hospitals, 
home-care palliative care services, and full-time palliative 
care physicians. The two available professional process in-
dicators are the per capita rate of participation from each 
country in EAPC conferences as retrieved from EAPC 
records (EAPC congresses) andthe per capita number of 
PubMed publications per year, retrieved with the search string 
(“palliative care” OR “hospice care”). In a secondary analysis, 
for additional clarity, to better inform the debate on the puta-
tive inhibition of the development of palliative care by legally 
regulated physician-assisted dying, we ranked the countries 
involved for each indicator as well as on an index composed 
of all rankings. 
3. Results 
3.1. The Belgian budget for palliative care before and since 
legal physician-assisted dying 
When in 2002 Belgium legally regulated physician-assisted 
dying, the passing of the law was preceded by a doubling of 
the federal budget for palliative care (Figure 1). 
Support for this boost was unanimous because the merits of 
palliative care were undisputed and physician-assisted dying, 
for which legal regulation was then in preparation, was widely 
considered unethical if requested and carried out for lack of 
available professional palliative care. Concomitantly with the 
law on euthanasia, a law was enacted to ensure universal 
access to professional multidisciplinary palliative care 
(Bernheim et al. 2008). This law made palliative care a citi-
zen‟s right, anticipating the Prague charter that was recently 
proposed by the European Association for Palliative care 
(EAPC) (Radbruch, de Lima, Lohmann, Gwyther, & Payne, 
2013). The total Belgian federal expenditure for palliative 
care, including the national health-insurance expenditure, has 
grown consistently by an annual average of almost 10 % since 
the regulation of physician-assisted dying (Figure 1). This far 
exceeds the governmental norm for growth of health-care 
expenditure, which was 4.5% over inflation as of 2003, but 
since 2013 stands at 2% (Gerkens&Merkur, 2010). Accor-
dingly, Belgian palliative care has expanded considerably 
(Federal Evaluation Cell on Palliative Care, 2008). Only 10 % 
of Belgian physicians think that the physician-assisted dying 
legislation was detrimental to the development of palliative 
care (Smets, Cohen, Bilsen, Van Wesemael, Rurup, & 
Deliens, 2011).  
3.2. How does the level of development of palliative care in 
Belgium and the Netherlands compare with other European 
countries? 
Table 1. Rankings (#) and scores (between brackets) of specific structural palliative care resources and scientific process indi-
cators, per million inhabitants 
 
The 
Netherlands 
Belgium 
(Flanders) 
 UK Spain France Germany 
Structural indicatorsa        
1) Inpatient units (PCUs and hospices) #1 (5·3) #2 (4·7)  #3(3·7) #5 (2·2) #6 (1·3) #4 (3·0) 
2) Palliative care beds #2 (43·9) #3 (34·8)  #1 (53·1) #4 (25·3) #6 (26·6) #5 (24·6) 
3) Palliative support teams in hospitals  #4 (3·1) #1 (12·4)  #2 (5·1) #5 (0·6) #3 (5·1) #6 (0·7) 
4) Home care services NA #3 (2·4)  #1 (5·9) #2 (3·2) #4 (1·4) #5 (0·4) 
5) Palliative care physicians (full time) #5 (0·6) #4 (2·3)  #2 (7·4) #1 (11·3) #3 (6·0) NA 
Mean rank for structural indicators 3·0 2·6  1·8 3·.4 4·4 5·0 
Overall ranking for structural indicators 3 2  1 4 5 6 
Scientific and professional process indicators        
6) PubMed publications on palliative care 1991 – 2011b #1 (55·1) #2 (45·0)  #3 (39·8) #6 (8·8) #5 (13·7) #4 (18·3) 
7) Average proportionate participation in EAPC confer-
encesc 
#2 (0·26) #1 (0·62)  #3 (0·22) #4 (0·12) #5 (0·19) #6 (0·07) 
Mean rank for scientific and professional process indicators 1·5 1·5  3 5 5 5 
Overall ranking for scientific and professional process 
indicators 
1 1  2 3 3 3 
Overall level of palliative care        
Mean rank for all indicators 2·50 2·29  2·14 3·86 4·71 5·00 
Overall ranking 3 2  1 4 5 6 
asource: EAPC Atlas of Palliative Care 2005 (Centeno et al., 2007) 
bsource: Briefing paper from the EAPC (Chambaere et al., 2011b) 
cMean % participants per million inhabitants in the 12 research and general EAPC conferences between 2000 and 2011 (successively in Berlin, Palermo, Lyon, 
The Hague, Stresa, Aachen, Venice, Budapest, Trondheim, Vienna, Glasgow and Lisbon) according to the EAPC records (EAPC congresses) 
NA=not available. 
The per capita values of the indicators and the rankings of 
the countries are shown in Table 1. The UK, where palliative 
care has the longest history, leads in terms of structural indi-
cators, followed by Belgium and the Netherlands. If also the 
scientific and professional process indicators are taken into 
account, the two countries with legally regulated physi-
cian-assisted dying are found close to on a par with the UK, 
while a second cluster with a lesser overall level of palliative 
care development according to the available indicators com-
prises Spain, France and Germany. 
4. Discussion 
Strengths and imitations of the study 
This study situates the issue of the development of palliative 
care among other controversies surrounding legally regulated 
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physician-assisted dying in the Benelux countries. That our 
study is the first to rank European countries for level of supply 
of palliative care services, is a strength. Another strength is 
also considering the expenditure for palliative care, an im-
portant indicator, not only of structural availability of services 
to the public, but also of their output.  
Our analysis has some limitations. For lack of criteria to 
do otherwise, we gave equal weights to all seven indicators 
though we recognise that, the organisation of palliative care 
being different between countries (Centeno et al., 2007a & b), 
some indicators may be more important in one country than in 
another. Also, some relevant variables of output are at present 
available only for Belgium, including palliative care expend-
iture and the fraction of deaths preceded by professional 
multidisciplinary palliative care (41% of all non-sudden 
deaths in 2007 as found by Van den Block et al., 2008). More 
robust conclusions will be possible when in the future such 
important indicators become available everywhere and also 
patient outcomes are taken into account. Also, importantly, 
for lack of measures of quality of care, we have dealt only 
with quantitative indicators.  
The question whether the culture of competent and com-
passionate care has been affected in the Benelux countries is 
more difficult to answer with only quantitative data, which 
moreover lack patient outcome measures. However, clues that 
if anything it has improved can be inferred from statements by 
respected spokespersons for palliative care in Belgium. Pal-
liative care workers who decline physician-assisted dying 
pledge to work hard at preventing such requests (Gamester & 
Van den Eynden, 2009) and those who have endorsed physi-
cian-assisted dying state to practice it in the philosophy of 
„integral palliative care‟, i.e. in the continuity of conventional 
palliative care, and with the same compassion (Bernheim et al. 
2008; Bernheim & Mullie, 2010).  
5. Conclusions 
This analysis, showing that in 2005 the physician-assisted 
dying-permissive countries were not lagging behind the 
non-permissive is in line with the EAPC report to the UK 
Commission on Assisted Dying (Chambaere et al., 2011) and 
earlier observations in Belgium (Bernheim et al., 2008), the 
Netherlands (Gordijn& Janssens, 2004), and the USA 
(Lindsay, 2009). All suggested that legal regulation of as-
sisted dying can be complementary with palliative care. Also 
in the Netherlands there is evidence that the legalisation of 
physician-assisted dying made the need for optimal palliative 
care more compelling, and boosted its development to its later 
high level (Janssens & ten Have, 2001;Gordijn& Janssens, 
2004). However, whereas in Belgium the development of 
palliative care preceded and arguably enabled legal physi-
cian-assisted dying (Bernheim et al., 2008), the sequence and 
relationship appears to be inversed in the Netherlands: pal-
liative care took off „with a vengeance‟ after the 2002 law. All 
the evidence suggests that also in the physician-assisted 
dying-permissive countries the mainstream palliative care 
tenet of prevention of physician-assisted dying (Saunders, 
1976) was an incentive to strengthen palliative care (Gor-
dijn& Janssens, 2000; Bernheim et al., 2008). 
In sum, the here reviewed and generated evidence con-
firms that palliative care and legally regulated physi-
cian-assisted dying can coexist and be synergistic. The evi-
dence from Belgium and the Netherlands during the first 
several years after the implementation of legally regulated 
physician-assisted dying does not verify the concern that the 
further development of palliative care would be stunted. 
However, some effects of legal physician-assisted dying on 
palliative care development may come to light only in the 
long run or in the form of phenomena that are not picked up 
by the currently available indicators. Therefore, there should 
be continued monitoring of both permissive and 
non-permissive countries, preferably also including patient 
outcomes.  
6. Keypoints 
• Both fundamental and pragmatic arguments are put forth 
against legally regulated physician-assisted dying, as since 
2002 in Belgium and the Netherlands. A prominent pragmatic 
concern is the possible stunting of the development of pallia-
tive care. 
• After the legalisation of physician-assisted dying, Bel-
gium‟s expenditure for palliative care increased by an annual 
10% and in 2005 the state of development of palliative care in 
the Netherlands and Belgium was close to on a par with the 
UK and ahead of the other non-permissive countries Spain, 
France and Germany. 
• Well-developed palliative care may be a pre-requisite of 
legal regulation of physician-assisted dying, but may also be a 
consequence. 
• Because effects of legal physician-assisted dying on pal-
liative care development may manifest only later or in other 
ways, evolutions in both permissive and non-permissive 
countries should be further monitored. 
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